Staphylococcus aureusAccessory Gene Regulator(agr)Group II: Is There a Relationship to the Development of Intermediate‐Level Glycopeptide Resistance?

Citations Over TimeTop 10% of 2003 papers

Abstract

We previously determined that all 6 Staphylococcus aureus strains with confirmed intermediate-level resistance to glycopeptides (glycopeptide intermediate S. aureus [GISA]) from the United States that we tested belonged to accessory gene regulator (agr) group II. In the present study, we found that 56% of surveyed bloodstream methicillin-resistant S. aureus isolates (n = 148) at our hospital were agr group II, whereas only 24% of methicillin-susceptible S. aureus isolates (n = 33) were agr group II (P = .001). Population analysis of genetically engineered agr-null and parent wild-type strains of groups I, II, and IV revealed that, when agr function is lost, the agr group II knockout S. aureus was most likely to develop glycopeptide heteroresistance after growth in 1 microg/mL but not 16 microg/mL vancomycin. This strain was unique in showing decreased autolysis after growth in these conditions. This study suggests that some S. aureus strains have an intrinsic survival advantage under a glycopeptide selective pressure, which is possibly related to reduced autolysis after exposure to subinhibitory concentrations of glycopeptide.

Related Papers

• → Rapid Identification of Methicillin-ResistantStaphylococcus aureusand Simultaneous Species Confirmation Using Real-Time Fluorescence PCR(2000)211 cited
• → Mild Staphylococcus aureus Skin Infection Improves the Course of Subsequent Endogenous S. aureus Bacteremia in Mice(2015)9 cited
• → Antibody response to teichoic acid and peptidoglycan in Staphylococcus aureus osteomyelitis(1987)18 cited
• → Production of Toxic Shock Syndrome Toxin 1 in a Mouse Model of Staphylococcus aureus Abscess Formation(1989)5 cited
• → Novel immunoenzymatic assay for identification of coagulase- and protein A-negative Staphylococcus aureus strains(1992)12 cited